Role of apoptosis resistance in immune evasion and metastasis of colorectal cancer

被引:22
作者
Liu, Kebin [1 ]
机构
[1] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA
关键词
Apoptosis; Fas; Metastasis; Immune evasion;
D O I
10.4251/wjgo.v2.i11.399
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The host immune system functions as a guardian against tumor development. It has been demonstrated that cytotoxic T lymphocyte (CTL)-mediated cytotoxic pathways function to inhibit or delay human colorectal cancer development. However, the host anti-tumor immune responses also 'edit' the tumor and select for more aggressive variants, resulting in immune evasion and tumor escape. Fas is a death receptor that mediates one of the major cytotoxic effector mechanisms of the CTLs. Fas is highly expressed in normal human colon epithelial cells but is frequently silenced in colorectal carcinoma, especially in metastatic colorectal carcinoma, suggesting that loss of Fas expression and function may be an immune evasion and tumor escape mechanism. In addition, recent studies indicated that Fas also mediates cellular proliferation signaling pathways to promote tumor development. Therefore, the death receptor Fas may not only transduce death signals to suppress tumor development but also activate cellular proliferation and the migration process to promote tumor growth and progression. Thus, understanding the mechanisms by which the Fas receptor and its associated protein complex transduces the death and survival signals may identify molecular targets for the development of therapeutic strategy to enhance the Fas-mediated death signals to increase the efficacy of cancer immunotherapy. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码:399 / 406
页数:8
相关论文
共 85 条
[71]   Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer [J].
Song, E ;
Chen, J ;
Ouyang, N ;
Su, F ;
Wang, M ;
Heemann, U .
BRITISH JOURNAL OF CANCER, 2001, 85 (07) :1047-1054
[72]   The Many Roles of FAS Receptor Signaling in the Immune System [J].
Strasser, Andreas ;
Jost, Philipp J. ;
Nagata, Shigekazu .
IMMUNITY, 2009, 30 (02) :180-192
[73]   Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma:: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease [J].
Sträter, J ;
Hinz, U ;
Hasel, C ;
Bhanot, U ;
Mechtersheimer, G ;
Lehnert, T ;
Möller, P .
GUT, 2005, 54 (05) :661-665
[74]   Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis [J].
Street, SEA ;
Cretney, E ;
Smyth, MJ .
BLOOD, 2001, 97 (01) :192-197
[75]   GENERALIZED LYMPHOPROLIFERATIVE DISEASE IN MICE, CAUSED BY A POINT MUTATION IN THE FAS LIGAND [J].
TAKAHASHI, T ;
TANAKA, M ;
BRANNAN, CI ;
JENKINS, NA ;
COPELAND, NG ;
SUDA, T ;
NAGATA, S .
CELL, 1994, 76 (06) :969-976
[76]   Decreased tumor surveillance in perforin-deficient mice [J].
vandenBroek, MF ;
Kagi, D ;
Ossendorp, F ;
Toes, R ;
Vamvakas, S ;
Lutz, WK ;
Melief, CJM ;
Zinkernagel, RM ;
Hengartner, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (05) :1781-1790
[77]   Perforin-mediated target-cell death and immune homeostasis [J].
Voskoboinik, Ilia ;
Smyth, Mark J. ;
Trapani, Joseph A. .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (12) :940-952
[78]   LYMPHOPROLIFERATION DISORDER IN MICE EXPLAINED BY DEFECTS IN FAS ANTIGEN THAT MEDIATES APOPTOSIS [J].
WATANABEFUKUNAGA, R ;
BRANNAN, CI ;
COPELAND, NG ;
JENKINS, NA ;
NAGATA, S .
NATURE, 1992, 356 (6367) :314-317
[79]   Apoptosis regulators bim and fas function concurrently to control autoimmunity and CD8+ T cell contraction [J].
Weant, Ashley E. ;
Michalek, Ryan D. ;
Khan, Islam U. ;
Holbrook, Beth C. ;
Willingham, Mark C. ;
Grayson, Jason M. .
IMMUNITY, 2008, 28 (02) :218-230
[80]  
Winter H, 1999, J IMMUNOL, V163, P4462